PTGS2 and metastatic malignant neoplasm in the lymph nodes: In this study, heterogeneity test revealed no significant heterogeneity when analyzing the associations between COX-2 expression and advanced tumor stage, high risk of lymph node metastasis and advanced TNM stage.